Search Contract Opportunities

Diltiazem SA (AB3) 24HR Capsules   3

ID: 36E79721R0038 • Type: Solicitation • Match:  95%
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Please sign-in to link federal registration and award history to assistant. Sign in to upload a capability statement or catalogue for your company

Some suggestions:
Please summarize the work to be completed under this opportunity
Do the documents mention an incumbent contractor?
I'd like to anonymously submit a question to the procurement officer(s)

Description

Posted: June 16, 2021, 3:12 p.m. EDT

..

Posted: June 16, 2021, 1:31 p.m. EDT
Background
The Department of Veterans Affairs, through its National Acquisition Center, is issuing a solicitation for the supply of Diltiazem SA (AB3) 24HR Capsules. The contract aims to establish national contract prices for pharmaceutical products distributed through VA and DOD Pharmaceutical Prime Vendor Programs.

Work Details
The contract involves the supply of Diltiazem (EQV-CARDIZEM AB3) 24HR Capsules in various strengths: 120MG, 180MG, 240MG, and 300MG, packaged in bottles of 90 capsules each. The packaging must include a safety-cap convertible to a non-safety cap and meet specific size requirements.

Offerors must provide pricing for the base year and four option years, including a Cost Recovery Fee of 0.5%. Each drug offered must have a unique NDC/UPC number.

Period of Performance
Base year plus four one-year options.

Place of Performance
Products will be delivered to all Department of Veterans Affairs facilities, Department of Defense facilities under the Pharmaceutical Prime Vendor Program, Indian Health Service facilities, Bureau of Prisons facilities, Captain James A. Lovell Federal Health Care Center, and State Veteran Homes participating in Option 2.

Overview

Agency
National Acquisition Center (NAC) [VA - HQ]
Response Deadline
June 30, 2021, 3:30 p.m. EDT Past Due
Posted
June 16, 2021, 1:31 p.m. EDT (updated: June 16, 2021, 3:12 p.m. EDT)
Set Aside
None
NAICS
325412 - Pharmaceutical Preparation Manufacturing
PSC
6505 - Drugs And Biologicals
Place of Performance
Not Provided
Source
Open
Current SBA Size Standard
1300 Employees
Pricing
Likely Fixed Price
Est. Level of Competition
Average
On 6/16/21 National Acquisition Center issued Solicitation 36E79721R0038 for Diltiazem SA (AB3) 24HR Capsules due 6/30/21. The opportunity was issued full & open with NAICS 325412 and PSC 6505.
Primary Contact
Title
Michael Olszewski
Name
michael.olszewski@va.gov   Profile
Email
michael.olszewski@va.gov
Phone
(708) 786-4966

Documents

Posted documents for Solicitation 36E79721R0038

Question & Answer

The AI Q&A Assistant has moved to the bottom right of the page

Opportunity Lifecycle

Procurement notices related to Solicitation 36E79721R0038

Award Notifications

Agency published notification of awards for Solicitation 36E79721R0038

IDV Awards

Indefinite delivery vehicles awarded through Solicitation 36E79721R0038

Incumbent or Similar Awards

Potential Bidders and Partners

Awardees that have won contracts similar to Solicitation 36E79721R0038

Similar Active Opportunities

Open contract opportunities similar to Solicitation 36E79721R0038

Additional Details

Source Agency Hierarchy
VETERANS AFFAIRS, DEPARTMENT OF > VETERANS AFFAIRS, DEPARTMENT OF > NAC PHARMACEUTICALS (36E797)
FPDS Organization Code
3600-36E797
Source Organization Code
500000036
Last Updated
June 16, 2021
Last Updated By
loren.audette@va.gov
Archive Date
Oct. 7, 2021